Tlie study of tumor escape from anti-angiogenic and conventional treatment, which is the theme of our PPG, requires utilization of various quantitative methodologies including microscopy, image analysis and statistical methods. The role of this Bioengineering and Biostatistics Core will be to provide expertise, resources, and support for the whole PPG in the areas of intravital microscopy, image analysis and biostatistical support. In addition, this core will be responsible for managing computational and database resources. Each project relies on intravital microscopy to quantify physiological and biophysical parameters. The core will continue its long-standing tradition of innovation in this area, pioneering new methods to address previously unanswerable questions as highlighted by five papers published in the New Technology secboo of Nature Medicine and three in Nature Methods. The bioengineering core will also acquire and maintain optical technologies for recording and analyzing images. Core leaders will instruct and assist researchers in the use of microscopy techniques and related image analysis software. All projects also require extraction of quantitative data from the intravital images;this core provides image analysis guidance and works closely with Project Leaders to develop new analysis algorithms when necessary. These activities require considerable knowledge of software and hardware systems, and are best served with a core facility. Finally, statistical methodology is an essential component of scientifically rigorous empirical research. Biostatistical expertise and support has been indispensable for planning an efficient experimental effort within all four projects and developing the statistical analysis plans. This expertise will also be vital for monitoring the experiments, accounting for measurement errors and other uncertainties for the analysis, summary, and interpretation of the collected data. The four research projects in this PPG could not succeed without the support ofthe Bioengineering and Biostatistics Core Component.

Public Health Relevance

This Core is recognized world-wide as a center for the development of innovative intravital microscopy techniques that allow PPG members to address critical and previously unanswerable questions in the quest to target and eradicate tumors. In addition, this Core supports PPG members through sophisticated image analysis and biostatistical consultation. These functions are critical to the success of all four projects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA080124-11A1
Application #
8299768
Study Section
Special Emphasis Panel (ZCA1-RPRB-O (J1))
Project Start
Project End
Budget Start
2012-05-01
Budget End
2013-04-30
Support Year
11
Fiscal Year
2012
Total Cost
$210,080
Indirect Cost
$89,633
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Jain, Rakesh K; Martin, John D; Stylianopoulos, Triantafyllos (2014) The role of mechanical forces in tumor growth and therapy. Annu Rev Biomed Eng 16:321-46
Chen, Yunching; Huang, Yuhui; Reiberger, Thomas et al. (2014) Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice. Hepatology 59:1435-47
Hong, Theodore S; Ryan, David P; Borger, Darrell R et al. (2014) A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma. Int J Radiat Oncol Biol Phys 89:830-8
Duda, Dan G; Ancukiewicz, Marek; Isakoff, Steven J et al. (2014) Seeds and soil: unraveling the role of local tumor stroma in distant metastasis. J Natl Cancer Inst 106:
Emblem, Kyrre E; Farrar, Christian T; Gerstner, Elizabeth R et al. (2014) Vessel caliber--a potential MRI biomarker of tumour response in clinical trials. Nat Rev Clin Oncol 11:566-84
Chen, Ou; Riedemann, Lars; Etoc, Fred et al. (2014) Magneto-fluorescent core-shell supernanoparticles. Nat Commun 5:5093
Hato, Tai; Goyal, Lipika; Greten, Tim F et al. (2014) Immune checkpoint blockade in hepatocellular carcinoma: current progress and future directions. Hepatology 60:1776-82
Jain, Rakesh K (2014) Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia. Cancer Cell 26:605-22
Pinho, Marco C; Polaskova, Pavlina; Kalpathy-Cramer, Jayashree et al. (2014) Low incidence of pseudoprogression by imaging in newly diagnosed glioblastoma patients treated with cediranib in combination with chemoradiation. Oncologist 19:75-81
Chauhan, Vikash P; Martin, John D; Liu, Hao et al. (2013) Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels. Nat Commun 4:2516

Showing the most recent 10 out of 169 publications